Liao T - Search Results

1

Long intergenic non-coding RNA 271 is predictive of a poorer prognosis of papillary thyroid cancer.

Ma B, Liao T, Wen D, Dong C, Zhou L, Yang S, Wang Y, Ji Q. Ma B, et al. Among authors: liao t. Sci Rep. 2016 Nov 11;6:36973. doi: 10.1038/srep36973. Sci Rep. 2016. PMID: 27833134 Free PMC article.

2

The Usefulness of Preoperative Thyroid-Stimulating Hormone for Predicting Differentiated Thyroid Microcarcinoma.

Shi RL, Liao T, Qu N, Liang F, Chen JY, Ji QH. Shi RL, et al. Among authors: liao t. Otolaryngol Head Neck Surg. 2016 Feb;154(2):256-62. doi: 10.1177/0194599815618388. Epub 2015 Nov 23. Otolaryngol Head Neck Surg. 2016. PMID: 26598500 Review.

3

Relationship of body mass index with BRAF (V600E) mutation in papillary thyroid cancer.

Shi RL, Qu N, Liao T, Wei WJ, Lu ZW, Ma B, Wang YL, Ji QH. Shi RL, et al. Among authors: liao t. Tumour Biol. 2016 Jun;37(6):8383-90. doi: 10.1007/s13277-015-4718-y. Epub 2016 Jan 5. Tumour Biol. 2016. PMID: 26733165

4

Expression, clinical significance and mechanism of Slit2 in papillary thyroid cancer.

Shi RL, Qu N, Liao T, Wang YL, Wang Y, Sun GH, Ji QH. Shi RL, et al. Among authors: liao t. Int J Oncol. 2016 May;48(5):2055-62. doi: 10.3892/ijo.2016.3412. Epub 2016 Mar 2. Int J Oncol. 2016. PMID: 26935705

5

DUSP4/MKP2 overexpression is associated with BRAF(V600E) mutation and aggressive behavior of papillary thyroid cancer.

Ma B, Shi R, Yang S, Zhou L, Qu N, Liao T, Wang Y, Wang Y, Ji Q. Ma B, et al. Among authors: liao t. Onco Targets Ther. 2016 Apr 15;9:2255-63. doi: 10.2147/OTT.S103554. eCollection 2016. Onco Targets Ther. 2016. PMID: 27143921 Free PMC article.

6

The impact of marital status at diagnosis on cancer survival in patients with differentiated thyroid cancer.

Shi RL, Qu N, Lu ZW, Liao T, Gao Y, Ji QH. Shi RL, et al. Among authors: liao t. Cancer Med. 2016 Aug;5(8):2145-54. doi: 10.1002/cam4.778. Epub 2016 Jun 5. Cancer Med. 2016. PMID: 27264532 Free PMC article.

7

The Trend of Age-Group Effect on Prognosis in Differentiated Thyroid Cancer.

Shi RL, Qu N, Liao T, Wei WJ, Wang YL, Ji QH. Shi RL, et al. Among authors: liao t. Sci Rep. 2016 Jun 8;6:27086. doi: 10.1038/srep27086. Sci Rep. 2016. PMID: 27272218 Free PMC article.

8

BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer.

Liao T, Qu N, Shi RL, Guo K, Ma B, Cao YM, Xiang J, Lu ZW, Zhu YX, Li DS, Ji QH. Liao T, et al. Oncotarget. 2017 Jan 3;8(1):238-247. doi: 10.18632/oncotarget.10825. Oncotarget. 2017. PMID: 27462868 Free PMC article.

9

Metastatic lymph node ratio can further stratify risk for mortality in medullary thyroid cancer patients: A population-based analysis.

Qu N, Shi RL, Lu ZW, Liao T, Wen D, Sun GH, Li DS, Ji QH. Qu N, et al. Among authors: liao t. Oncotarget. 2016 Oct 4;7(40):65937-65945. doi: 10.18632/oncotarget.11725. Oncotarget. 2016. PMID: 27588396 Free PMC article.

10

Programmed Death-Ligand 1 Expression in Papillary Thyroid Cancer and Its Correlation with Clinicopathologic Factors and Recurrence.

Shi RL, Qu N, Luo TX, Xiang J, Liao T, Sun GH, Wang Y, Wang YL, Huang CP, Ji QH. Shi RL, et al. Among authors: liao t. Thyroid. 2017 Apr;27(4):537-545. doi: 10.1089/thy.2016.0228. Epub 2017 Jan 24. Thyroid. 2017. PMID: 27825291

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,347 results

Search Page

Filters